Computer tool for measuring movement side effects
Part of Brain & nervous system clinical trials.
This study uses a computer program to objectively measure movement problems caused by antipsychotic medications (called extrapyramidal symptoms). The goal is to improve how these side effects are detected and monitored, which may help doctors adjust treatment more effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You do not have Parkinson's disease, epilepsy, or other major brain disorders (unless you are in the healthy volunteer group)
- You can understand and follow the study tasks
- You are either a healthy volunteer or have schizophrenia with antipsychotic-induced movement problems
- If you have a psychiatric condition, you are currently taking antipsychotic medication
- You can give informed consent to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental once-daily tablet for moderate-to-severe tardive dyskinesia, a condition causing uncontrollable repetitive movements. It aims to see if the drug is safe and reduces these symptoms over time.
This trial tests whether an oral medication, NBI-1065890, can reduce the involuntary muscle movements caused by long-term use of antipsychotic drugs. It is for adults with moderate to severe tardive dyskinesia who also have a stable mental health condition like schizophrenia or bipolar disorder.
This trial tests a remote way to assess people newly diagnosed with Parkinson's disease, to help monitor their condition and guide care.
This trial uses new technology (like sensors or apps) to help diagnose and monitor Parkinson's disease early. Researchers want to see if a simple, widespread healthcare service model can improve care. Both people with Parkinson's and healthy volunteers are needed.
This study tests a computer-based tool that aims to predict and prevent impulse control disorders (like compulsive gambling or shopping) caused by certain Parkinson's medications. If you take a dopamine agonist, this tool might help your doctor adjust your treatment to avoid these side effects.
This study tests a digital tool (NMS Assist) to help people with Parkinson's and their caregivers track and manage non-motor symptoms like mood, sleep, and thinking changes. Participation takes place from home using a smartphone or tablet.
Hear when a new Extrapyramidal Symptoms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.